An international perspective on the basis of pay-for-performance

The Quality and Outcomes Framework: QOF - Transforming General Practice

Volumn , Issue , 2016, Pages 147-155

  Starfield, Barbara ^a   Mangin, Dee ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85049897759     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (35)

1. Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005; 83(3): 457-502.
2. Iliffe S. From General Practice to Primary Care. Oxford, UK: Oxford University Press; 2008.
3. National Institute for Health and Clinical Excellence. Management of Hypertension in Adults in Primary Care. London, UK: National Institute for Health and Clinical Excellence; 2006.
4. Gervas J, Starfield B, Heath I. Is clinical prevention better than cure? Lancet. 2008; 372(9654): 1997-9.
5. Millett C, Saxena S, Ng A, et al. Socio-economic status, ethnicity and diabetes management:an analysis of time trends using the health survey for England. J Public Health. 2007; 29(4): 413-19.
6. Hurtado MP, Swift EK, Corrigan J; Institute of Medicine Committee on the National Quality Report on Health Care Delivery and Board on Health Care Services. Envisioning the National Health Care Quality Report. Washington, DC: National Academies Press; 2001.
7. International Alliance of Patients' Organizations. Declaration on Patient-Centred Healthcare. London, UK; 2006. Available at: www.patientsorganizations.org/show article.pl?id=712&n=312 (accessed 17 October 2008).
8. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ. 1996; 312(7023): 71-2.
9. Potts M, Prata N, Walsh J, et al. Parachute approach to evidence based medicine. BMJ. 2006; 333(7570): 701-3.
10. Campbell SM, Roland MO, Shekelle PG, et al. Development of review criteria for assessing the quality of management of stable angina, adult asthma, and noninsulin dependent diabetes mellitus in general practice. Qual Health Care. 1999; 8(1): 6-15.
11. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009; 301(8): 831-41.
12. Baigent C, Blackwell L, Collins R, et al.; Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678): 1849-60.
13. Berger JS. Aspirin as preventive therapy in patients with asymptomatic vascular disease. JAMA. 2010; 303(9): 880-2.
14. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545-59.
15. Chan AW, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004; 291(20): 2457-65.
16. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med. 2008; 5(11): e217; discussion e217.
17. Godlee F. We want raw data, now. BMJ. 2009; 339: b5405.
18. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002; 287(5): 612-17.
19. Gerstein, Miller, Byington, et al., Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002; 287(5): 612-17.
20. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007; 357(21): 2109-22.
21. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004; 291(14): 1701-12.
22. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005; 294(6): 716-24.
23. Bon Hoem J, Kerse N, Scahill S, et al. Use of aspirin and statins for cardiovascular risk reduction in New Zealand: the residential care story. J Prim Health Care. 2009; 1(3): 184-9.
24. Oakley Browne MA, Wells JE, Scott KM. Te Rau Hinengaro: The New Zealand Mental Health Survey. Wellington, NZ: Ministry of Health; 2006.
25. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002; 287(3): 337-44.
26. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4): 483-5.
27. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990; 150(4):841-5.
28. Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: a New Health System for the 21st century. Washington, DC: National Academies Press; 2001.
29. Loeppke R, Taitel M, Richling D, et al. Health and productivity as a business strategy. J Occup Environ Med. 2007; 49(7): 712-21.
30. Mangin D, Sweeney K, Heath I. Preventive health care in elderly people needs rethinking. BMJ. 2007; 335(7614): 285-7.
31. Callahan D. The Troubled Dream of Life. Washington, DC: Georgetown University Press; 2000.
32. Starfield B. Primary care and equity in health: the importance to effectiveness and equity of responsiveness to peoples' needs. Humanity Soc. 2009; 33(1-2): 56-73.
33. Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009; 7(4): 357-63.
34. Starfield B, Weiner JP, Mumford L, et al. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991; 26(1): 53-74.
35. World Health Organization. International Classification of Functioning, Disability, and Health. Geneva, Switzerland: World Health Organization; 2001.